Trends in the use of local intervention for metastatic hormone‐naïve prostate cancer: A multicenter retrospective study
Ryuma Tanaka(Hirosaki University), Chikara Οhyama(Hirosaki University), Takuya Oishi(Hirosaki University), Akihiro Ito(Tohoku University), Sadafumi Kawamura(Miyagi Prefectural Hospital Organization), Norihiko Tsuchiya(Yamagata University), Shintaro Narita(Akita University), Hikari Miura(Hirosaki University), Shigeto Ishidoya(Sendai City Hospital), Koji Mitsuzuka(Pacific Northwest Diabetes Research Institute), Senji Hoshi, Toshikazu Tanaka, Shingo Hatakeyama(Hirosaki University), Toshihiko Sakurai(Sojo University), Tomonori Habuchi(Akita University)
Cited by 0
Related Papers
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
|New England Journal of Medicine|2020|1.5k
Prospective Randomized Phase II Trial of a Single Early Intravesical Instillation of Pirarubicin (THP) in the Prevention of Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: The THP Monotherapy Study Group Trial
|Journal of Clinical Oncology|2013|253